2/20/2014 8:56:15 AM
SAN DIEGO, Feb. 20, 2014 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced its scheduled participation in the following investor events in February:
Help employers find you! Check out all the jobs and post your resume.
comments powered by